Mycamine Lyophilisate For Solution For Injection 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Mycamine: Lyophilisate for solution for injection (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MICAFUNGIN (MYE ka FUN jin) is an antifungal medicine. It is used to treat or prevent certain kinds of fungal or yeast infections.

In-Depth Information

Mycamine 100mg Powder for Injection

NDC: 004693211
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Peritonitis, Candidiasis Prophylaxis, Esophageal Candidiasis, Intraabdominal Infections, Intraabdominal Abscess, Candidiasis, Candidemia

Sometimes used for but not FDA approved for the following conditions:
Pneumonia, Aspergillosis Prophylaxis, Febrile Neutropenia, Aspergillosis, Bone And Joint Infections, Endocarditis, Infectious Arthritis, Osteomyelitis, Oropharyngeal Candidiasis (thrush)

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Mycamine 100mg Powder for Injection

Reported Side Effects for Mycamine 100mg Powder for Injection

Hives Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Coagulopathy Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Brain Dysfunction Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Bleeding In The Brain Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Liver Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Enlarged Liver Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Pancytopenia Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Severe Allergy Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Fluid Around The Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Suddenly Stopped Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
High Bilirubin Level Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Delirium Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Irregular Heart Beat Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
High Sodium Levels Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
4.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
5.0-25.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
6.0-7.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
7.0-22.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
7.0-22.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
9.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
9.0-44.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
10.0-26.0%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
11.0%*
Severity: MILD
Onset: RAPID
Anemia Incidence:
13.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
15.0-75.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
16.0-26.0%*
Severity: MILD
Onset: EARLY
Irritated Blood Vessels Incidence:
19.0%*
Severity: MODERATE
Onset: RAPID
Inability To Sleep Incidence:
37.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mycamine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5